These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27533966)
1. Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence. Kjeldsen SE; Fadl Elmula FE; Os I; Persu A; Jin Y; Staessen JA Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):48-56. PubMed ID: 27533966 [TBL] [Abstract][Full Text] [Related]
2. Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension. Fadl Elmula FE; Larstorp AC; Kjeldsen SE; Persu A; Jin Y; Staessen JA Front Physiol; 2015; 6():9. PubMed ID: 25709581 [TBL] [Abstract][Full Text] [Related]
3. Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence. Persu A; Fadl Elmula FEM; Jin Y; Os I; Kjeldsen SE; Staessen JA Eur Cardiol; 2014 Dec; 9(2):110-114. PubMed ID: 30310496 [TBL] [Abstract][Full Text] [Related]
4. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332 [TBL] [Abstract][Full Text] [Related]
5. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798 [TBL] [Abstract][Full Text] [Related]
6. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ; Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922 [TBL] [Abstract][Full Text] [Related]
7. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation? Epstein M; de Marchena E J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995 [TBL] [Abstract][Full Text] [Related]
8. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819 [TBL] [Abstract][Full Text] [Related]
9. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation. Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693 [TBL] [Abstract][Full Text] [Related]
10. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence. Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458 [TBL] [Abstract][Full Text] [Related]
11. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels. Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366 [TBL] [Abstract][Full Text] [Related]
12. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA; Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721 [TBL] [Abstract][Full Text] [Related]
14. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension. Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527 [TBL] [Abstract][Full Text] [Related]